October 13, 2022 02:20 PM EDT

Novartis to cut up to 400 jobs at Dublin campus

Nicole DeFeudis

Editor

Weeks after CEO Vas Narasimhan unveiled a “US-first” strategy in reshaping Novartis, the Swiss pharma giant has revealed plans to cut around 400 jobs at …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Novartis to cut up to 400 jobs at Dublin campus

Nicole DeFeudis

Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Exclusive: First-of-its-kind infant DNA edit leads to apparent cure in disease that set back field 25 years ago

Gene editing startup Scribe Therapeutics lets go of staff as it preps for the clinic

Astellas stops developing autologous cell therapy using tech from Xyphos buyout

Resilience cuts 120 employees at a former bluebird gene therapy site

Updated: Galapagos to split into two companies, slash headcount as it eyes turnaround

MaaT Pharma touts ‘unprecedented’ Phase 3 efficacy of graft-versus-host disease treatment

No­var­tis to cut up to 400 jobs at Dublin cam­pus

Editor

Sign up to read this article for free.

more like this

Bachem

Bubendorf, BL, Switzerland

Novartis to cut up to 400 jobs at Dublin campus